1 in 14 Patients
Require Arrhythmia
Intervention:
Remote Patient Management
with the Wearable
Cardioverter Defibrillator
EHRA EUROPACECARDIOSTIM 2015
Satellite Symposium
23 June 2015
12:45 – 13:45
Room: Venezia
Faculty
Chairpersons
PD Dr. Johannes Sperzel
Bad Nauheim, Germany
Prof. Jean-Claude Deharo
Marseille, France
Speakers
Dr. Oliver Przibille
Frankfurt, Germany
PD Dr. Jan Steffel
Zurich, Switzerland
With the online patient
management system, you
can diagnose arrhythmic
events including:
+
Sustained VT
+
Non-sustained VT
+
Atrial arrhythmias/SVT
+
Severe bradycardia/Asystole
www.zoll.com/EHRAEUROPACE-CARDIOSTIM2015
Program Overview
This program will discuss how the wearable cardioverter
defibrillator (WCD) provides protection from Sudden
Cardiac Death with a connection to your patients’
changing cardiac condition through the online patient
management system. Arrhythmic events captured in the
online patient management system provide actionable
insights and the opportunity to modify the treatment path
for patients protected by the WCD.
Program Agenda
MINUTES PRESENTER
OBJECTIVE
10
All Faculty
Introduction
15
PD Dr. Jan Steffel
Discussion of the utility of
remotely managed patient
clinical and diagnostic
markers to effect better
outcomes
15
Dr. Oliver Przibille
Overview of the online
patient management system
and clinical case scenarios
for its use in treating patients
in addition to shocking VT/VF
20
All Faculty
Panel Discussion/Q&A
Reference: Kutyifa V, Goldenberg I, Zareba W, et al. Results from the prospective registry of
patients using the wearable defibrillator (WEARIT-II Registry). Presented as Late Breaking Clinical
Trial at ESC Congress 2014, Sept 3, 2014.
© 2015 ZOLL Medical Corporation.
ZOLL and LifeVest are registered trademarks of ZOLL Medical
Corporation in the United States and/or other countries.
20C0466 Rev FI